High-performance terminator and application thereof in improving gene expression
Through large-scale terminator mutation library construction and FlowSeq technology, high-performance terminators were analyzed and applied, which solved the problem of improving the expression level of upstream genes in prokaryotes, and achieved significant improvements in upstream gene mRNA stability and fermentation product yield.
Patent Information
- Application Number
- CN202411181746.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-11-22
AI Technical Summary
In prokaryotes, existing studies have lacked the relationship between terminator characteristics and mRNA stability of upstream genes, making it difficult to design terminator elements that efficiently improve upstream gene expression levels.
Through large-scale terminator mutation library construction and FlowSeq technology, high-performance terminator features are systematically analyzed, and high-performance terminator is applied in different expression systems to replace terminators of genes to be expressed, satisfying features including low minimum free energy and cardiovascularization. The base is rich in GC base and the secondary structural stability of AT bases downstream of U-tract.
In prokaryotes, the mRNA level of upstream genes increased by 30% to 60% after replacing high-performance terminators, and the yield of fermentation products increased by 40% to 70%, significantly improving the upstream gene expression level.
Smart Images

Figure CN118995710A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a high-performance terminator and application thereof in improving gene expression, belonging to the field of biotechnology. Background Art
[0002] The terminator is located in the non-coding region at the 3' end of the gene. Its most basic function is to terminate the transcription of the upstream gene and avoid the occurrence of transcriptional read-through. Transcriptional read-through will lead to the restriction of the RNA polymerase cycle process, thus placing an additional burden on the overall transcription efficiency and affecting the expression of downstream genes. Therefore, exploring the factors that affect the termination efficiency of terminators has always been the focus of research in the field of terminators.
[0003] However, in addition to terminating gene transcription read-through, more and more studies have shown that terminators also play an important role in improving upstream gene expression and maintaining the stability of upstream gene mRNA. In eukaryotes, terminators are composed of the 3'-UTR untranslated region and the region that terminates mRNA transcription. It can resist the hydrolysis of intracellular enzymes and protect the mRNA of upstream genes from degradation. This protective effect is closely related to the 3'-UTR region. The content of GC bases in the 3'-UTR, the length of the region, and the secondary structure will affect the protective effect of the terminator on the upstream gene mRNA.
[0004] In prokaryotes, although some studies have shown that terminators can maintain the stability of upstream gene mRNA by inhibiting the degradation of hydrolases and thus increase the expression level of upstream genes, there is still a lack of relevant research to explore the relationship between terminator characteristics and upstream gene mRNA stability. Clarifying this relationship is crucial for designing terminator elements that can efficiently increase the expression level of upstream genes. Summary of the invention
[0005] Based on the construction of a large-scale terminator mutation library and FlowSeq technology, this study systematically analyzed the characteristics of high-performance terminators that are beneficial to improving the stability of upstream gene mRNA, and applied high-performance terminators in different expression systems to improve the expression level of upstream genes.
[0006] The first object of the present invention is to provide a high-performance terminator, the nucleotide sequence of the terminator is shown in SEQ ID NOs. 1-4.
[0007] The second object of the present invention is to provide use of the terminator in improving gene expression.
[0008] Furthermore, the application is to replace the terminator of the target gene to be expressed with the terminator.
[0009] Furthermore, the gene expression is carried out in prokaryotes.
[0010] Furthermore, the prokaryotic organism is Escherichia coli.
[0011] Furthermore, the target genes to be expressed include nicotinamide riboside kinase and thioadenosylmethionine synthetase.
[0012] The third object of the present invention is to provide a method for designing and screening high-performance terminators, comprising the following steps:
[0013] S1, using the strong terminator T7 as a template, random mutations were performed at the hairpin base and the downstream position of the U-tract to construct a terminator mutation library;
[0014] S2, inserting the terminator mutation library fragment into the dual fluorescent probe plasmid by restriction digestion and ligation, and transforming and expressing;
[0015] S3. Group the expression systems according to the expression level of the reporter gene to obtain high-performance terminators.
[0016] Furthermore, the method further includes analyzing the characteristics that a high-performance terminator should satisfy, including the following steps:
[0017] S01. Cut the sequence using cutadapt software and calibrate the sequence using prinseqlite software. The quality score of a single base should be above 30.
[0018] S02. Use RNA folding and RNA evaluation software in Vienna RNA package to predict the secondary structure of terminators and calculate the minimum free energy ΔG of each terminator.
[0019] S03. Analyze the characteristics that a high-performance terminator should meet from three perspectives: terminator strength, base composition of the mutation site, and differences in the secondary structure of the terminator;
[0020] Among them, the characteristics that a high-performance terminator should meet include a low minimum free energy of the terminator, a secondary structure of the terminator that is rich in GC bases at the hairpin base and rich in AT bases downstream of the U-tract.
[0021] Furthermore, the transformation and expression in step S2 is carried out in the Escherichia coli BL21 (DE3) system.
[0022] Furthermore, in step S3, the reporter gene is red fluorescent protein.
[0023] Beneficial effects of this application:
[0024] The present invention uses the strong terminator T7 as a template, randomizes several bases at the hairpin base and the downstream position of the U-tract to construct a large terminator mutation library, sorts and sequences the library based on the FlowSeq technology, and analyzes the high-performance terminator characteristics that are beneficial to improving the expression level of the upstream gene. The high-performance terminator is applied in two different expression systems expressing the Nrk enzyme and the Sam2 enzyme, and the upstream gene mRNA level and the fermentation product yield are detected. It is found that after replacing the high-performance terminator, the upstream gene mRNA level of the two expression systems is increased by 30% to 60%, and the yield of the corresponding fermentation product is increased by 40% to 70%. Therefore, the scheme provided by the present invention is of great significance for improving the expression level of the upstream gene in the prokaryotic system. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 :Schematic diagram of large-scale terminator mutation library construction and FlowSeq technology.
[0026] Figure 2 : The fermentation product yield and upstream gene mRNA level detection results of the parent strain RSF and the mutant strains RSF-1 to RSF-4 after replacing the high-performance terminator.
[0027] Figure 3 : The fermentation product yields and upstream gene mRNA level detection results of the parent strain GSH and the mutant strains GSH-1 to GSH-4 after replacing the high-performance terminator. DETAILED DESCRIPTION
[0028] The preferred embodiments of the present invention are described below. It should be understood that the embodiments are for better explaining the present invention and are not used to limit the present invention.
[0029] The following experiments, if no specific conditions are specified, are carried out under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used, if the manufacturer is not specified, are all conventional products that can be purchased commercially. Unless otherwise specified, all percentages, ratios or parts are by weight.
[0030] Unless otherwise defined, all professional and scientific terms used herein have the same meanings as those familiar to those skilled in the art. In addition, any methods and materials similar or equivalent to the contents described herein can be applied to the present invention.
[0031] The determination method or culture method involved in the following examples is as follows:
[0032] LB medium: peptone 10.0 g L -1 , NaCl 10.0 g·L -1 , yeast powder 5.0g·L -1 , sterilize at 121℃ for 20min.
[0033] PBS buffer: potassium chloride 0.2 g·L -1 , sodium chloride 8.0g·L -1 , Potassium dihydrogen phosphate 0.24 g·L -1 , disodium hydrogen phosphate 1.44 g·L -1 ,; pH 7.4, sterilize at 121℃ for 20min.
[0034] Biomass determination method (UV-visible photometer): dilute the samples at each sampling point to an appropriate multiple to OD 600 The value is 0.2-0.8, and the absorbance is measured at a wavelength of 600nm.
[0035] mRNA level detection method: Take 1 mL of fermented bacterial liquid and extract RNA from it using an RNA extraction kit, then reverse transcribe the RNA into cDNA using a reverse transcription kit, and finally detect the mRNA level by Quantitative Real-time PCR (qPCR).
[0036] Method for determining the yield of nicotinamide mononucleotide (NMN) by shake flask fermentation: 10 μL of the bacterial suspension of the parent strain RSF and the mutant strains RSF-1 to RSF-4 were streaked onto a solid LB plate (Kan resistance) and incubated at 37°C and 220 r·min -1 Culture for 12 h under the same conditions. Pick a single bacterium and inoculate it into a 10 ml LB vial (Kan resistance) at 37 °C and 220 r·min. -1 Culture for 12 h, then take 600 μL and add to 30 mL LB bottle (Kan resistance), 37 ° C, 220 r·min -1 Culture for 2 h until OD is between 0.4 and 0.6. Add IPTG to a final concentration of 0.3 mM, 25 °C, 220 r·min -1 Fermentation for 12 hours, add substrate and react for 2 hours at 25℃, 12000r·min -1 After centrifugation for 10 min, the supernatant was passed through a water membrane and the NMN production was determined using HPLC.
[0037] The method for determining the yield of adenosylmethionine (SAM) by shake flask fermentation was as follows: 10 μL of the bacterial suspension of the parent strain GSH and the mutant strains GSH-1 to GSH-4 were streaked onto a solid LB plate (Kan resistance) and incubated at 37°C and 220 r·min -1 Culture for 12 h under the same conditions. Pick a single bacterium and inoculate it into a 10 mL LB vial (Kan resistance) at 37 °C and 220 r·min. -1 Incubate for 12 h, then take 1 mL and add to 50 mL LB bottle (Kan resistance), 37 ° C, 220 r·min-1 Culture for 2 h until OD is between 0.6 and 0.8. Add IPTG at a final concentration of 0.01 mM, 25 °C, 220 r·min -1 After 12 h of fermentation, 2 mL of fermentation liquid was washed twice (Tris hydrochloric acid), and the substrate was added to react at 37 °C for 2 h. 20% perchloric acid was added to terminate the reaction. The reaction was continued at 12000 r·min. -1 After centrifugation for 10 min, the supernatant was passed through a water membrane and the SAM yield was determined using HPLC.
[0038] The following are specific embodiments:
[0039] Example 1: Construction of large-scale terminator mutation library and FlowSeq technology
[0040] (1) Construction of terminator mutation library
[0041] The template DNA of the terminator mutation library is divided into conservative regions and mutation regions. First, the dry powder of the forward and reverse chain primers is diluted to 10μM, 10μL of each is taken and mixed, and then the annealing reaction is performed. After the annealing is completed, the sample is slowly cooled to room temperature, and then the second strand RNA is amplified using Klenow enzyme, incubated at 25℃ for 20min, and then EDTA with a final concentration of 10mM is added, and the reaction is carried out at 75℃ for 20min to remove the enzyme activity. After the reaction is completed, the 5' end of the sample after the above reaction is phosphorylated with T4 polyphosphorylase enzyme to prepare for the next ligation reaction.
[0042] The plasmid was digested with restriction enzymes Hind III and EcoR I to obtain a linearized plasmid, and then the linearized plasmid was ligated with the previously phosphorylated fragment using T4 DNA ligase overnight at 4°C. The ligation product was divided into 20 competent E. coli BL21 (DE3) cells, placed on ice for 30 minutes, then heated at 42°C for 90 seconds, and placed on ice again for 5 minutes. LB medium was then added to each test tube to make the final volume reach 1 mL. Incubate at 37°C, 220 r·min -1 After culturing for 1 hour, the liquids in the 10 test tubes were added to 100 mL of LB liquid medium supplemented with kanamycin and incubated at 37°C and 220 r·min -1 Overnight culture under the same conditions.
[0043] (2) Flow cytometry
[0044] Take 2 mL of overnight culture solution and add it to 100 mL of LB liquid medium supplemented with kanamycin, and add IPTG with a final concentration of 0.5 mM. Incubate at 37°C and 220 r / min. -1Then, 1 mL of bacterial solution was taken and incubated at 12000 r·min -1 The cells were centrifuged at 1000 rpm, washed twice with PBS solution, and then resuspended in 1 mL PBS solution. The cells were then screened using a flow cytometer (Becton Dickinson FACSAria III) with an excitation wavelength of 561 nm and an emission wavelength of 610 / 20 nm to detect mRFP1 fluorescence. The flow cytometer data were analyzed using FlowJo v10 software and the mean fluorescence intensity was calculated. Finally, the cells were divided into weak terminator bin1, medium-intensity terminator bin2, and strong terminator bin3 according to the intensity of downstream red fluorescence.
[0045] (3) High-throughput sequencing
[0046] The collected cells were incubated at 37°C and 220 r / min -1 The cells were revived for 2 h under the conditions of 4% paraformaldehyde and 1% paraformaldehyde, and then inoculated into 100 mL of LB medium supplemented with kanamycin and incubated at 37°C at 220 r·min -1 The culture was shaken at a speed of 100 for 12 hours, and 1 mL of bacterial solution was taken to extract the plasmid. The target primers were used for PCR amplification to obtain the DNA amplification product. Next, RNA was extracted from the bacterial solution using an RNA extraction kit, and the RNA was reverse transcribed into cDNA using a reverse transcription kit. Then, PCR amplification was performed using the target primers to obtain the cDNA amplification fragment. Finally, 1000 ng of DNA and RNA amplification fragments were taken from each of the three bins for high-throughput sequencing, and the sequencing platform was the MGISEQ-2000 platform of BGI.
[0047] See the attached diagram for the relevant process Figure 1 .
[0048] (4) Data processing
[0049] For the fastq file after sequencing, the following steps are taken to process the sequence data: Use cutadapt software to excise the sequence and use prinseqlite software to accuse the sequence. The quality score of a single base should be above 30. At the same time, there should be at least one U base in the first three bases at the U-tract position of the sequence. The RNA folding and RNA evaluation software in the Vienna RNA package toolkit are used to predict the secondary structure of the terminator and calculate the minimum free energy ΔG of each terminator.
[0050] After data processing, we analyzed the terminator strength, base composition of the mutation site, and secondary structure differences from three perspectives, and concluded that the terminator that is beneficial to improving the stability of upstream gene mRNA should meet the following characteristics: high termination efficiency, rich GC bases at the hairpin base and rich AT bases downstream of the U-tract, and stable secondary structure.
[0051] Based on the above characteristics, we designed and screened four high-performance terminators, h-1 to h-4, and will verify their regulatory effects in two different expression systems.
[0052] Table 1 Sequence information of high performance terminators h-1 to h-4
[0053]
[0054] Example 2: Fermentation performance and upstream gene mRNA level analysis of the parent strain RSF and mutant strains RSF-1 to RSF-4
[0055] Using Escherichia coli BL21 (DE3) as the host, the Nrk gene was added behind the original T7 promoter of the plasmid pET28a to construct a parent strain RSF capable of fermenting and producing NMN; further, the high-performance terminator (h-1 to h-4) was inserted into the plasmid of strain RSF to replace the original T7 terminator, thereby producing four mutant strains RSF-1 to RSF-4.
[0056] The parent strain RSF and mutant strains RSF-1 to RSF-4 were fermented in shake flasks, and the mRNA level of the upstream gene was detected. The strain RSF was used as a control to evaluate the application effect of the high-performance terminator in the expression system. The results are as follows Figure 2 shown.
[0057] (1) Comparison of NMN production of fermentation products
[0058] The NMN yield of RSF fermentation was 1.0 g·L -1 The NMN yield produced by the mutant strains after replacing the high-performance terminator increased to varying degrees. Among them, the NMN yield produced by RSF-4 fermentation was the highest, reaching 1.64g·L -1 , which is 64% higher than the fermentation yield of RSF.
[0059] (2) Comparison of upstream gene mRNA levels
[0060] The results of upstream gene mRNA levels of the parent strain RSF and mutant strains RSF-1 to RSF-4 showed that compared with the parent strain RSF, the upstream mRNA levels of the mutant strains RSF-1 to RSF-4 were greatly increased, among which the upstream gene mRNA level of RSF-4 even reached 4 times that of RSF.
[0061] Example 3: Fermentation performance of parent strain GSH and mutant strains GSH-1 to GSH-4 and analysis of upstream gene mRNA levels
[0062] Using Escherichia coli BL21 (DE3) as the host, the Sam2 gene was added behind the original T7 promoter of the plasmid pET28a to construct a parent strain GSH capable of fermenting and producing SAM; further, a high-performance terminator (h-1 to h-4) was inserted into the plasmid of the strain GSH to replace the original T7 terminator, thereby producing four mutant strains GSH-1 to GSH-4.
[0063] The parent strain GSH and mutant strains GSH-1 to GSH-4 were fermented in shake flasks, and the mRNA level of the upstream gene was detected. The strain GSH was used as a control to evaluate the application effect of the high-performance terminator in the expression system. The results are as follows Figure 3 shown.
[0064] (1) Comparison of the yield of fermentation product SAM
[0065] The SAM yield from GSH fermentation was 0.28 g·L -1 The fermentation product yields of GSH-1 to GSH-4 of the mutant strains all exceeded 0.4 g·L -1 , compared with the fermentation yield of GSH, it increased by 40% to 60%.
[0066] (2) Comparison of upstream gene mRNA levels
[0067] Compared with the upstream gene mRNA level of GSH in the parent strain, the upstream gene mRNA levels of GSH-1 to GSH-4 increased by 30% to 55%, among which the upstream gene mRNA levels of GSH-1, GSH-3 and GSH-4 increased by more than 50%.
[0068] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. A high performance terminator, characterized in that: The nucleotide sequences of the terminators are shown in SEQ ID NOs. 1-4.
2. Use of the terminator according to claim 1 in improving gene expression.
3. The use according to claim 2, characterized in that: The application is to replace the terminator of the target gene to be expressed with the terminator.
4. The use according to claim 2, characterized in that: The gene expression is carried out in prokaryotes.
5. The use according to claim 4, characterized in that: The prokaryotic organism is Escherichia coli.
6. The use according to claim 3, characterized in that: The target genes to be expressed include nicotinamide riboside kinase and thioadenosylmethionine synthetase.
7. A method for designing and screening high-performance terminators, characterized in that: The steps include: S1, using the strong terminator T7 as a template, random mutations were performed at the hairpin base and the downstream position of the U-tract to construct a terminator mutation library; S2, inserting the terminator mutation library fragment into the dual fluorescent probe plasmid by restriction digestion and ligation, and transforming and expressing; S3. Group the expression systems according to the expression level of the reporter gene to obtain high-performance terminators.
8. The method according to claim 7, characterized in that The method further includes analyzing the characteristics that a high-performance terminator should meet, including the following steps: S01. Cut the sequence using cutadapt software and calibrate the sequence using prinseqlite software. The quality score of a single base should be above 30. S02. Use RNA folding and RNA evaluation software in Vienna RNA package to predict the secondary structure of terminators and calculate the minimum free energy ΔG of each terminator. S03. Analyze the characteristics that a high-performance terminator should meet from three perspectives: terminator strength, base composition of the mutation site, and differences in the secondary structure of the terminator; Among them, the characteristics that a high-performance terminator should meet include a low minimum free energy of the terminator, a secondary structure of the terminator that is rich in GC bases at the hairpin base and rich in AT bases downstream of the U-tract.
9. The method according to claim 7, characterized in that: In step S2, the transformation and expression is carried out in the Escherichia coli BL21 (DE3) system.
10. The method according to claim 7, characterized in that In step S3, the reporter gene is red fluorescent protein.
